ID   CL-6
AC   CVCL_C6N2
DR   Wikidata; Q116048773
RX   CelloPub=CLPUB00729;
RX   PubMed=21517231;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   PubMed=21517231;
RA   Chaijaroenkul, Wanna
RA   Viyanant, Vithoon
RA   Mahavorasirikul, Wiratchanee
RA   Na-Bangchang, Kesara
RT   "Cytotoxic activity of artemisinin derivatives against
RT   cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines.";
RL   Asian Pac. J. Cancer Prev. 12:55-59(2011).
//
RX   CelloPub=CLPUB00729;
RA   Akarasereenont, Pravit
RA   Aiamsa-ard, Tipsuchon
RA   Chotewuttakorn, Sirikul
RA   Thaworn, Athiwat
RT   "Cholangiocarcinoma cell induced platelet aggregation via activation
RT   of thrombin and cyclooxygenase.";
RL   Siriraj Med. J. 61:8-12(2009).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan, Abdulkadir
RA   Yenigun, Ali
RA   Soma, Daiki
RA   Aksu, Eric
RA   Lopez, Kevin
RA   Park, Yujin
RA   Cross-Najafi, Arthur
RA   Li, Ping
RA   Kundu, Debjyoti
RA   House, Michael G.
RA   Chakraborty, Sanjukta
RA   Glaser, Shannon
RA   Kennedy, Lindsey
RA   Francis, Heather
RA   Zhang, Wen-Jun
RA   Alpini, Gianfranco D.
RA   Ekser, Burcin
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//